(PRAB) Amundi Prime Euro Gov Bonds - Ratings and Ratios
Government, Bonds, Euro, Short-Term
Description: PRAB Amundi Prime Euro Gov Bonds October 27, 2025
Amundi Prime Euro Gov Bonds 0-1Y UCITS ETF DR Cap (ticker PRAB) is a German-domiciled exchange-traded fund that tracks the FTSE EUR EuroDep 3-Month EUR index, offering exposure to ultra-short-term sovereign debt denominated in euros.
Key metrics as of the latest data (Q3 2024) include an expense ratio of 0.12 %, a weighted average maturity of roughly 0.7 years, and a 30-day SEC yield near 1.1 %. The fund’s assets under management are about €1.2 billion, and its holdings are concentrated in high-quality eurozone governments (average credit rating AA-). Its performance is closely tied to the European Central Bank’s policy rate and short-term money-market conditions, which have been influenced by recent inflation trends and the ECB’s gradual rate-cut cycle.
If you want to dig deeper into PRAB’s risk-adjusted returns and scenario analysis, ValueRay’s analytics tools provide a useful, data-driven perspective.
PRAB ETF Overview
| Market Cap in USD | 591m |
| Category | EUR Ultra Short-Term Bond |
| TER | 0.05% |
| IPO / Inception | 2020-10-08 |
PRAB ETF Ratings
| Growth Rating | 70.0% |
| Fundamental | - |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -14.6% |
| Analyst Rating | - |
PRAB Dividends
Currently no dividends paidPRAB Growth Ratios
| Growth Correlation 3m | 98.6% |
| Growth Correlation 12m | 99.9% |
| Growth Correlation 5y | 81.8% |
| CAGR 5y | 2.81% |
| CAGR/Max DD 3y (Calmar Ratio) | 18.47 |
| CAGR/Mean DD 3y (Pain Ratio) | 165.57 |
| Sharpe Ratio 12m | -2.92 |
| Alpha | -28.84 |
| Beta | 1.690 |
| Volatility | 0.46% |
| Current Volume | 66.7k |
| Average Volume 20d | 32k |
| Stop Loss | 20.7 (-3.3%) |
| Signal | 0.46 |
What is the price of PRAB shares?
Over the past week, the price has changed by +0.07%, over one month by +0.14%, over three months by +0.46% and over the past year by +2.42%.
Is Amundi Prime Euro Gov Bonds a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PRAB is around 18.97 EUR . This means that PRAB is currently overvalued and has a potential downside of -11.36%.
Is PRAB a buy, sell or hold?
What are the forecasts/targets for the PRAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 21.9 | 2.1% |
PRAB Fundamental Data Overview January 01, 1970
Market Cap EUR = 512.6m (512.6m EUR * 1.0 EUR.EUR)
Beta = 1.69
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 512.6m EUR (512.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 512.6m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 512.6m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 12.24% (E(512.6m)/V(512.6m) * Re(12.24%) + (debt-free company))
Discount Rate = 12.24% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)